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Abstract
The expansion of Covid-19 has severely hit the community’s health all over the world, killing
hundreds of thousands of people, subjecting health systems to an enormous stress (besides
derailing economic activities and altering personal and social behavior). Two elements are
essential to monitor the evolution of the pandemic as well as to analyze the effectiveness of
the response measures: reliable data and useful indicators. We present an indicator that
helps to assess the impact of Covid-19 on the community’s health, combining two different
components: the extent of the pandemics (i.e. the share of the population affected) and its
severity (the intensity of the disease on those affected). The severity measure derives from
the application of an evaluation protocol that allows comparing population distributions
based on the proportions of those affected with different health conditions. We illustrate the
functioning of this indicator over a case study regarding the situation of the Italian regions on
March 9 (the beginning of the confinement) and April 8, 2020, one month later.
1. Introduction
The speed and spread of transmission of COVID-19 have forced governments all over the
world to implement strong defensive measures to control the expansion of the epidemics and
avoid the collapse of their health care systems. Assessing the effectiveness of those measures
calls for surveillance strategies on its application and continuous monitoring of the disease’s
evolution. Both aspects require the availability of reliable data and adequate evaluation proto-
cols that transform those data into helpful indicators [1]. Several variables measure particular
instances of the pandemics (e.g. reproduction rate, mortality rate, positive rate). Here we shall
focus on the overall evaluation of the impact of Convid-19 on the community’s health.
According to the general recommendations of the World Health Organization [2], there
are three variables to consider in a pandemic of this nature: how many people are infected
(transmissibility), how severely sick get the infected individuals, and how the pandemic affects
the health-care system and society. In a similar vein, the US Department of Health and
Human Services has developed the Pandemic Severity Assessment Framework (PSAF) [3].
The PSAF proposes two assessment dimensions, transmissibility, and clinical severity, and dis-
tinguishes on how to apply those measurement protocols depending on the stage of the epi-
demic [4]. The European Centre for Disease Prevention and Control (ECDC) has recently
advised to “monitor the intensity, geographic spread and severity of COVID-19 in the
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population to estimate the burden of disease, assess the direction of recent time trends, and
inform appropriate mitigation measures” [5]. The ECDC recommends countries to compre-
hensively testing suspected cases and to report the number of confirmed cases, distinguishing
between those hospitalized, those in intensive care units (ICU), and those deceased.
There is, therefore, an extensive agreement on the variables that should be considered to
track the evolution and the impact of COVID-19 on community’s health. There is also consen-
sus on the way of approaching the evaluation, which can be regarded as a conventional way to
assess the global impact of a given phenomenon on a population: computing both extent (the
share of people involved) and severity (how intensely the event affects that population).
We know that countries have only been computing a fraction of the people infected by the
virus, especially at the beginning of the pandemics, depending on detection policies and test
availability [6]. Something similar can be said of the reports on the numbers of people dead
and cured, as there is evidence that different countries (or even different regions within a
country) apply diverse protocols to compute those cases. As a result, we do not have an exact
picture of the dynamics of the disease [7]. Yet, it is still essential to get an idea on how things
are evolving [8], if only to determine the effectiveness of the solutions that are being imple-
mented, helping to calculate the needs of sanitary supplies, the pressure on the equipment and
human resources of the health systems, and predicting the evolution of the disease and the pro-
gressive return to normality. Hence the need to tackle the second challenge: finding adequate
indicators of the extent and severity of the pandemic.
Evaluating the severity of the disease requires analyzing the distribution of the population
affected in different health conditions (e.g., hospitalized, in intensive care units, recovered,
deceased). Ideally, we would like to have a numerical indicator that allows for quantitative
comparisons to assess both the direction and the size of the changes in severity. This involves
the design of an evaluation formula that, as a general rule, adopts the structure of a weighted
average or a generalized mean of the relative frequencies of those health conditions. That is,
we need to assign weights to each of those conditions and decide, for instance, how much we
value the death of one person relative to the healing of another. Our conclusions on the sever-
ity of the pandemics will depend on those judgments, which are extremely difficult to deter-
mine for both technical and ethical reasons.
Herrero and Villar [9, 10] have developed an evaluation procedure that does not require
introducing those judgments, which can help to assess the severity of the impact of COVID-
19. Relying on the comparison of the probabilities that members of a community being worse-
off than members of some other, we obtain a cardinal measure of the relative severity with
which the pandemic affects different populations. Note that populations here may refer to the
people infected in a group of countries, regions within a country, demographic groups, or dif-
ferent points in time. We can thus apply this evaluation procedure to estimate the impact on
the community’s health of COVID-19 in a variety of ways.
We organize the paper as follows. Section 2 presents the evaluation protocol, which consists
of the product of a measure of the extent and a measure of the severity. Section 3 illustrates
this evaluation protocol regarding the situation of Italy and its regions in two points in time:
the beginning of the confinement and one month later. Finally, Section 4 contains a short dis-
cussion on some of the critical aspects of this evaluation procedure and its applicability.
2. The proposal
2.1 The indicator
We propose to measure the impact of COVID-19 by an indicator made out of two compo-
nents: extent (share of the population affected by the virus) and severity (a measure of the
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relative health situation of that population). The indicator, denoted by ICo19, consists of the
product of those two variables. That is, ICo19 = Extent×Severity.
More formally, if we call nah the population affected by the virus in society h, nh the total
population of that society, and sh the measure of severity, our indicator for population h is
given by:
ICo19 hð Þ ¼
nah � sh
nh
The indicator provides an intuitive measure of the degree to which each community is
affected by the disease, as it describes how many people are affected, times how severely
affected they are, relative to the population size. This is a standard measurement rod to esti-
mate the impact of a given phenomenon on a population subgroup; in particular, it is the con-
ventional approach regarding poverty measures [11, 12].
Note that we have used the expression “population affected by the virus” for nah, rather than
“population infected”, and “extent” for nah=ni, rather than “incidence”. The reason is that, espe-
cially during the initial phase of the contagion, those registered as infected were only those
who required some kind of medical treatment or preventive measure (e.g. isolation). Monitor-
ing is nowadays more thorough and present data also capture people with light or no symp-
toms. Needless to say, the indicator works with whatever reference population we consider, as
its internal logic is independent of that aspect. Yet, the interpretation of the results is condi-
tional on that reference population. We shall be precise on this respect in the illustration pre-
sented in Section 3 and will say more on this subject in the discussion (Section 4).
2.2 The evaluation protocol for severity
Let us now address the question of how to measure the severity. The formal problem consists
of comparing a collection of populations affected by the virus, G = {1, 2, . . ., g}, in terms of the
distributions of their members over an ordered set of health conditions, c = 1, 2, . . ., C. We
describe the health situation of population h by a vector a(h) = (ah1, ah2,. . .,ahC), where ahc is
the fraction of people affected by the virus in population h with health condition c. That is, we
can write ahc ¼ nach =n
a
h, where n
ac
h is the number of individuals in population h who are affected
by the virus and exhibit health condition c. By construction, ahc � 0;
PC
c¼1 ahc ¼ 1, for all h.
To assess the relative situation of those populations, regarding the intensity of the pandem-
ics, we compare the likelihood of getting a worse health condition for representative members
of those societies. To be precise, let phk denote the probability that a member of society h exhib-
its a worse health condition than a member of society k. Assuming that those categories are
ordered from worst to best, such a probability obtains as follows:
phk ¼ ah1ðak2 þ � � � þ akCÞ þ ah2ðak3 þ � � � þ akCÞ þ � � � þ ahðC  1ÞakC
Let ehk = ekh stand for the probability of a tie and define qhk ¼ phk þ 12 ehk (i.e., we split the
probability of a tie evenly).
To compare the severity of the pandemics in two societies, h, and k, we apply the following
principle: the severity measures of those societies are proportional to the corresponding proba-
bilities of being relatively worse off. That is if we call sh, sk the severity measures, we let:9,10
sh
sk
¼
qhk
qkh
Note that, by construction, this equation has a degree of freedom. That is, we can freely set
the units in which we measure severity. In the two-society case, by letting sh = 1, we can rewrite
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the former equation as follows:
sh ¼
qhk
1   qhk
That is, sh tells us how likely is that an individual from society h is in a worse health condition
than a individual from society k, relative to the complementary case.
When there are more than two societies involved this simple formulation has to be
adjusted. Yet, we can extend this principle easily by taking expectations over the expression
sh ¼
qhk
qkh
sk (we cannot rely on bilateral comparisons as they are not transitive). That is, we mea-
sure severity in society h relative to the rest by the following formula:
sh ¼
1
g  1
P
k6¼hqhksk
1
g  1
P
k6¼hð1   qhkÞ
The previous expression has a similar meaning as before, even though now each probability in
the numerator is weighted by the corresponding measure of severity.
The vector or those sh values is called the balanced worth [10] and obtains as the dominant
eigenvector of a Perron matrix P built as follows. The elements in the diagonal are of the form
Rk = (g−1)−∑h6¼k qkh; the off-diagonal elements are just the probability values qhk. That is,
P ¼
R1 q12 . . . q1ðg  1Þ q1g
q21 R2 . . . q2ðg  1Þ q2g
. . . . . . . . . . . .
qg1 qg2 . . . qgðg  1Þ Rg
0
B
B
B
B
@
1
C
C
C
C
A
The balanced worth provides a relative evaluation of the severity of the pandemic in the dif-
ferent populations considered. The structure of this matrix ensures that the balanced worth
vector s = (s1,. . .,sg), which corresponds to the solution to the equation s = Ps, always exists,
and it is positive and generically unique, except for the choice of units, as it has one degree of
freedom. Thus, we have to normalize those values with respect some reference level that will
define the units in which we measure this variable.
Remark. There is a friendly and freely accessible algorithm hosted in the Ivie website
https://web2011.ivie.es/balanced-worth/balanced-worth-vector.php that performs instantly all
calculations required to obtain this vector. This algorithm uses the mean, by default, to nor-
malize the values of the corresponding eigenvector (i.e. we measure the values obtained in
terms of percentages of the mean value). This normalization can be easily modified.
3. A case study: The impact of Covid-19 on the Italian regions
Let us see how this evaluation protocol works in a case study. This section serves the purpose
of illustrating the application of the methodological approach we propose, rather than to pro-
vide an empirical study. We consider two different applications that show the measurement
we can obtain in a synchronic and in a diachronic context. We first compare the situation of
the Italian regions on April 8, 2020, which is one month after Italy decreed the confinement.
Here we measure the impact of the Covid-19 in the Italian regions relative to the whole coun-
try. With this exercise we capture the diversity of the situations in the Italian regions at a par-
ticular point in time. Then we address the change experienced by those regions between
March 9, the day in which the confinement started in Italy, and April 8. Here we compare the
situation of the Italian regions relative to the initial state (Italy as a whole on March 9), so that
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we can have an estimate of the evolution of the pandemics within the regions and also relate
how diverse was the situation at the beginning of the confinement and one month later.
The data come from the Italian Ministry of Health (Ministero della Salute), which are freely
available at its webpage [13]. They referred to the people infected by the virus who had been
identified due to the gravity of their symptoms. They included those treated in hospitals, those
who have been isolated at home, cured, or have died. There was not, at that early stage, any
estimate of those who might be infected but showed no apparent symptoms. We refer to the
population registered as infected in that period as infected with worrisome symptoms (IWS, for
short).
3.1 A day in the life of Italy with Covid-19
Table 1 describes the cumulative number of the IWS population on April 8. Individuals in this
group presented one of the following five health conditions, ordered from worst to best:
deceased, in intensive care units (ICU), hospitalized (non-ICU), isolated at home, and cured.
Table 2 shows that Italian regions exhibited a large variability regarding the extent of the
COVID-19 (see the last column of the table), with a coefficient of variation around 0�8. The
highest values were in the Northern regions: Lombardia, Emilia-Romagna, Piemonte, Marche,
Liguria, Trento, Bolzano, and Val d’Aosta. We can decompose the extent figure into two com-
ponents: the product of the ratio of the IWS over the number of tests performed, and the ratio
between the number of tests per 100,000 inhabitants. The first term tells how the IWS relates
to the number of tests (a measure of the detection rate). The second term is an index of how
intense the search of IWS was between regions.
Table 1. IWS by health state (Italian regions, April 8, 2020).
Deceased Intensive care Hospital Isolated at home Cured Total
Abruzzo 179 62 331 1141 146 1859
Basilicata 14 17 48 205 13 297
Bolzano 183 65 268 948 371 1835
Calabria 60 15 170 570 44 859
Campania 221 97 608 2154 188 3268
Emilia Romagna 2234 361 3769 8980 2890 18234
Friuli V.G. 169 41 162 1212 634 2218
Lazio 244 196 1241 2011 574 4266
Liguria 654 153 1109 1983 1007 4906
Lombardia 9722 1257 11719 15569 15147 53414
Marche 652 133 974 2455 645 4859
Molise 13 4 30 147 32 226
Piemonte 1378 423 3493 7073 1516 13883
Puglia 219 90 639 1509 177 2634
Sardegna 59 31 112 697 76 975
Sicilia 133 65 563 1265 133 2159
Toscana 392 260 1066 4231 430 6379
Trento 255 77 354 1509 407 2602
Umbria 50 41 155 627 416 1289
Valle d’Aosta 102 20 120 466 142 850
Veneto 736 285 1554 8332 1503 12410
Total 17669 3693 28485 63084 26491 139422
Source: Ministero della Salute (Italy)
https://doi.org/10.1371/journal.pone.0238970.t001
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Data show that the more intense the search, the more cases detected (a coefficient of corre-
lation of 0�624). Despite the variability of the ratio between IWS and the number of tests per-
formed, the extent variable is orthogonal with that measuring the tests per 100.000 inhabitants
(a correlation coefficient of 0�1). That is, data suggest that the differential impact of the disease
over the regions was not due to the differential search intensities.
Fig 1 displays the proportions of the IWS population into the different health conditions
(arranged by increasing number of deceased). The proportions of those deceased and cured
presented a large variability (with coefficients of variation of 0�4 and 0�57, respectively). For
those isolated at home, the variability was relatively low (CV = 0�18), whereas that of those hos-
pitalized or at the ICU was somewhere in between (CV = 0�3 in both cases).
Fig 1 illustrates well the challenge of transforming those data into an indicator of severity
and gives a hint on how things can appear depending on the way of attaching values to the
health conditions. To obtain the severity measure described in Section 2 (the so-called balance
worth), we just have to plug the data generating this figure into the web page mentioned in the
Remark above. This measure tells us about the relative health situation of the IWS in the Italian
regions. To facilitate the comparison, we normalize the values by setting Italy to 100. Table 3
reports the evaluation of the severity of COVID-19. There are two features worth commenting.
First, the variability was relatively small, with a coefficient of variation of 0�155. Second, some
of the regions with higher severity were in the South, where the extent was much smaller.
The indicator we propose to measure the impact of COVID-19 over the community’s
health simply obtained by weighing extent by severity. The resulting data appear in Table 3.
The variability of the impact was extremely high, with a coefficient of variation above 0�8.
Table 2. IWS, tests, and population (Italian regions, April 8, 2020).
IWS/Test Test per 100,000 inhabs. IWS per 100,000 inhabs.
Abruzzo 11�73% 1208 142
Basilicata 9�01% 586 53
Bolzano 9�73% 3552 345
Calabria 5�74% 769 44
Campania 11�76% 479 56
Emilia Romagna 23�27% 1757 409
Friuli V.G. 8�94% 2041 183
Lazio 7�74% 937 73
Liguria 28�00% 1130 316
Lombardia 31�88% 1665 531
Marche 27�72% 1149 319
Molise 11�29% 655 74
Piemonte 28�63% 1113 319
Puglia 10�75% 608 65
Sardegna 11�48% 518 59
Sicilia 7�87% 549 43
Toscana 10�46% 1635 171
Trento 19�63% 2450 481
Umbria 9�14% 1599 146
Valle d’Aosta 28�78% 2350 676
Veneto 7�60% 3328 253
Total 17�27% 1337 231
Source: Ministero della Salute (Italy)
https://doi.org/10.1371/journal.pone.0238970.t002
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Lombardia and Valle d’Aosta presented the highest impact, followed by Trento and Emilia-
Romagna. The lowest impact corresponded to Sicilia, Calabria, and Basilicata.
3.2 Changes after one month of confinement
We now discuss how the situation changed between March 9 and April 8. Table 4 provides the
relevant information for those two dates, setting Italy to 100 on March 9, both for severity and
impact. There are several features worth commenting.
During this month the impact in the whole country multiplied by a factor of 10, whereas in
some regions multiplied by more than 40 times: Bolzano (70 times), Trento (60 times), Valle
d’Aosta (54 times), Basilicata (49 times), Calabria (47 times), and Sicilia (43 times). All these
regions exhibited low impact values on March 9 (especially the last three regions). The regions
with a higher impact on March 9 display much smaller factors: Lombardia (6 times), Marche (8
times), Veneto (12 times), Piamonte (17 times), Liguria (18 times). As a consequence, the extreme
diversity between the Italian regions, as measured by the coefficient of variation, exhibits a substan-
tial reduction between March and April (from 0�347 to 0�185 for severity and from 1�519 to 0�853
for impact). This fact may indicate that confinement is an effective policy in fighting the disease.
Severity decreased substantially in most of the regions, with an overall reduction of 33%. This
reduction happened more intensely in those regions with worse indicators so that we observe a
sharp decline in its variability, which dropped by almost one half. This suggests that the health sys-
tem was responding correctly, and did it more intensely in those regions more in need.
4. Discussion
Many countries provide daily reports on the effects of COVID-19 regarding the spread of the
infection, the numbers of people dead, hospitalized, in intensive care units, and cured. Those
Fig 1. IWS shares by health condition (Italian regions, April 8, 2020). Source: Ministero della Salute (Italy).
https://doi.org/10.1371/journal.pone.0238970.g001
PLOS ONE An index for the impact of COVID-19
PLOS ONE | https://doi.org/10.1371/journal.pone.0238970 September 11, 2020 7 / 14
data evolve differently both within each population (they increase and decrease and do it at dif-
ferent rates) and between populations (e.g., countries, regions, age groups). This complex
dynamics makes it challenging to get an idea of the global impact of COVID-19 on commu-
nity’s health. We have presented a protocol intended to address this evaluation problem. It
measures impact as the product of extent and severity. Extent is simply the share of those regis-
tered as infected in the population whereas severity is a more sophisticated indicator.
4.1 Severity
Severity is measured by comparing distributions across different health conditions of the pop-
ulations affected by the virus. The type of comparison proposed here (the balanced worth) per-
mits one to get a cardinal measure without having to attach weights to those health conditions.
We depart, therefore, from other approaches based on setting ex-ante scores to those states
(e.g. the weights used to ponder different health states in an advanced phase of the epidemics
in PSAF) and on the “disability-adjusted life years” metrics used to estimate the “burden of dis-
ease.” The nature of the available information at that early stage of contagion makes it difficult
to apply those evaluation formulae [4].
This severity measure is based on the relative likelihood of getting a worse health condition
for a representative member of an affected population. The formula is intuitive and corre-
sponds to a well-known mathematical tool, similar to the one used by Google to order web
pages or the principle behind the Eigenfactor [14, 15]. The evaluation obtains as the dominant
eigenvector of a Perron matrix associated with a Markov chain [16]. Therefore, calculations
Table 3. Severity and impact of COVID-19 in the Italian regions (April 8, 2020).
Severity Impact COVID-19
Abruzzo 106�63 65�43
Basilicata 102�81 23�49
Bolzano 86�45 129�30
Calabria 104�52 19�96
Campania 103�71 25�29
Emilia Romagna 102�60 181�62
Friuli V.G. 63�01 49�79
Lazio 109�86 34�51
Liguria 103�50 141�77
Lombardia 100�56 231�14
Marche 109�68 151�27
Molise 81�33 26�04
Piemonte 114�15 157�49
Puglia 116�20 32�89
Sardegna 89�57 23�06
Sicilia 113�93 21�30
Toscana 100�21 74�20
Trento 89�47 186�26
Umbria 60�64 38�37
Valle d’Aosta 92�08 269�64
Veneto 83�95 91�94
Total 100 100
Source: Ministero della Salute (Italy) and own calculations.
https://doi.org/10.1371/journal.pone.0238970.t003
PLOS ONE An index for the impact of COVID-19
PLOS ONE | https://doi.org/10.1371/journal.pone.0238970 September 11, 2020 8 / 14
are conventional, and we know precisely how the evaluation protocol works and what infor-
mation conveys. With the advantage of providing quantitative estimates and having designed a
specific algorithm that is freely available.
It is worth mentioning that severity is not a variant of another elementary indicator, such as
the lethality rate (i.e., the ratio between deceased and affected). Fig 2 illustrates this fact by
comparing severity and lethality in the Italian regions on April 8, normalizing both rates set-
ting Italy to 100. The correlation coefficient is below 0�28.
4.2 Population subgroups
Our way of comparing distributions implies that the evaluation is relative. That is, we obtain
an assessment of how a population fares relative to others. This fact is essential both to under-
stand the meaning of the evaluation and to think of the different questions this protocol per-
mits to address. Besides the types of the evaluation presented here, regarding the comparison
of different populations (Italian regions) at a given point in time and different dates, we may
consider different types of individuals (depending on age, gender, race, wealth, etc.) or particu-
lar population subgroups [10].
A population subgroup of particular relevance is that corresponding to those who are posi-
tive at the reference day, that is, those registered as infected who are in intensive care units, at
the hospital or isolated at home. Let us call PAP this population subgroup, as a shorthand for
Positive At Present. The impact of Covid-19 over the PAP population is a measure of the effort
currently required from the health system, as we discount from the population affected those
already cured and those deceased.
Table 4. Severity and impact in the Italian regions on March 9 and April 8 (Italia = 100 on March 9 for both variables).
Severity March 9 Severity April 8 Impact March 9 Impact April 8
Abruzzo 138 58 21 541
Basilicata 68 56 4 194
Bolzano 149 51 17 1159
Calabria 97 58 4 168
Campania 74 58 10 215
Emilia-R. 93�5 63�5 191 1709
Friuli V.G. 51 36 26 432
Lazio 116 66 13 315
Liguria 146�5 70�5 68 1468
Lombardia 105�4 73�3 377 2561
Marche 111 69 155 1447
Molise 82 46 25 224
Piemonte 159�6 68�6 84 1439
Puglia 107�4 68 9 293
Sardegna 71 48 5 188
Sicilia 60 64 4 182
Toscana 92�6 55�1 34 620
Trento 69 52�3 28 1655
Umbria 55�3 34�6 12 333
V. d’Aosta 56�2 53�8 44 2395
Veneto 66 47�2 66 786
Total 100 64�7 100 983
Source: Ministero della Salute (Italy) and own calculations.
https://doi.org/10.1371/journal.pone.0238970.t004
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Fig 3 describes the shares of the PAP on April 8 in the Italian regions, using the data in
Table 1. They show that Lazio, Liguria, Lombardia and Piemonte were the regions with higher
shares of people in hospitals (including those in ICU). Those with smaller shares corresponded
to Friuli V.G., Molise, Sardegna and Veneto.
Table 5 provides the evaluation of the Italian regions on April 8, in terms of severity and
impact, for the PAP population. As it was the case for the IWS population, the impact has
much larger variability than the severity (a coefficient of variation of 0.759 with respect to
0.166). Valle d’Aosta, Lombardia, Trento, Emilia-Romagna, Liguria and Bolzano were the
regions with a more substantial impact of Covid-19 on the PAP. Calabria, Campania, Molise
and Sicilia were those with a smaller impact.
It is also interesting to observe how severity has changed along this month by comparing
our two reference dates and anchoring the evaluation by setting Italy to 100 on March 9, as
shown in Table 6. There are two remarkable features that those data reveal. First� the sharp
decline of the severity values in all regions, to almost one half of the initial value for the whole
country. Second, the even sharper reduction of the variability between regions (60% reduction
in the coefficient of variation. which drops from 0�462 to 0�168). That suggests, once more,
that the health system reacted in a balanced way absorbing the shock according to need.
4.3 The dynamics of the pandemics
There is a strong suspicion that, at the initial phase of the pandemics, the number of people
infected was much larger than reported. The multiplication of the tests and the surveys on
Fig 2. Lethality rate and severity in the Italian regions, on March 9 (Italy = 100 for both variables). Source: Ministero della Salute (Italy).
https://doi.org/10.1371/journal.pone.0238970.g002
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Fig 3. PAP shares by health condition (Italian regions, April 8, 2020). Source: Ministero della Salute (Italy).
https://doi.org/10.1371/journal.pone.0238970.g003
Table 5. Severity and impact of COVID-19 in the population of positive on April 8, 2020. Italian regions.
Severity Impact
Abruzzo 85�48 63�34
Basilicata 84�04 25�54
Bolzano 86�61 132�35
Calabria 82�68 20�31
Campania 83�59 26�10
Emilia Romagna 95�08 177�11
Friuli V.G. 68�17 50�30
Lazio 117�88 43�81
Liguria 110�99 147�17
Lombardia 126�10 226�70
Marche 94�83 140�32
Molise 74�07 27�80
Piemonte 103�66 165�68
Puglia 97�77 34�41
Sardegna 72�18 23�43
Sicilia 98�59 23�65
Toscana 82�92 78�28
Trento 79�99 181�72
Umbria 82�99 49�07
Valle d’Aosta 81�06 247�69
Veneto 73�31 96�30
Italia 100 100
Source: Ministero della Salute (Italy) and own calculations.
https://doi.org/10.1371/journal.pone.0238970.t005
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seropositivity have started capturing people infected with light or no symptoms so that nowa-
days data are richer and more informative.13 Those data might induce a revision of the extent
and severity of the pandemics in that initial phase, recurring to some statistical techniques.
Indeed, there is already some statistical analysis on the “excess of deaths”, which suggests that
the number of people registered as deceased by the virus was also underestimated [17]. As a
consequence, some revisions on the data on the evolution of the pandemics are to be expected.
The new data available entail a change in the nature of the reference population and has
implications on the impact analysis. Measuring severity in this richer scenario will require
introducing another health condition, corresponding to infected people with light or no symp-
toms. As severity is a relative measure, the effect of introducing this new category will depend
on the distribution of those infected but asymptomatic between the populations under
consideration.
Introducing that new health condition is a trivial change in the analysis presented in Section
3. Note that, in a synchronic analysis, this modification presents no particular problem. Things
are different in a diachronic analysis because the change in the population registered as
infected in March 2020 and in September 2020, say, involves an implicit change in the crite-
rion that defines those who are infected. It would thus be prudent, for the time being, to ana-
lyze the evolution of the impact within periods in which the recording criteria have not
changed much, or keeping as the reference population those infected with worrisome symp-
toms (the IWS population used in our empirical application), Alternatively, one may smooth
the effect of the change in the detection policy by making the impact analysis on a very short
period bases (e.g. daily) using a moving average approach [18, 19].
Table 6. Severity in the PAP population on March 9 and April 8 2020. Italian regions.
Mar-09 Apr-08
Abruzzo 140.42 44�47
Basilicata 57�26 37�70
Bolzano 159�81 44�09
Calabria 159�81 41�85
Campania 63�72 62�64
Emilia Romagna 77�63 49�55
Friuli V�G� 39�38 43�29
Lazio 107�48 58�68
Liguria 154�91 41�37
Lombardia 121�58 66�71
Marche 96�05 43�15
Molise 69�76 43�25
Piemonte 155�17 37�37
Puglia 90�56 34�45
Sardegna 59�73 36�88
Sicilia 53�39 51�30
Toscana 82�85 49�61
Trento 56�53 51�62
Umbria 42�08 45�30
Valle d’Aosta 43�56 42�51
Veneto 54�77 54�49
Total 100 52�50
Source: Ministero della Salute (Italy) and own calculations.
https://doi.org/10.1371/journal.pone.0238970.t006
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